Echocardiography (Mount Kisco, N.Y.) · 2026
Longitudinal Left Atrial Remodeling With Pharmacological Rhythm Versus Rate Control in Paroxysmal and Persistent Atrial Fibrillation.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chien Shao-Fu, Chin Chih-Hui, Chang Chao-Chien, Huang Shih-Yu, Chiou Hung-Yi
Аннотация
PURPOSE: Evidence regarding left atrial (LA) remodeling with pharmacological rhythm control remains limited, particularly in patients with atrial fibrillation (AF) outside heart-failure-specific populations.
METHODS: This single-center retrospective cohort included 156 adults with paroxysmal or persistent AF receiving mutually exclusive pharmacological rate-control (n = 92) or rhythm-control (n = 64) therapy who underwent two transthoracic echocardiograms. LA remodeling was assessed using serial echocardiography, and clinical outcomes were evaluated after the second examination.
RESULTS: Among 74 patients with paired left atrial volume index (LAVI) measurements, LAVI increased from 39.9 to 50.3 mL/m2 with rate control (p < 0.001) but remained unchanged with rhythm control (44.9 to 43.4 mL/m2; p = 0.465). After adjustment for baseline LAVI and clinical covariates, rhythm control was associated with a 9.38 mL/m2 lower follow-up LAVI (95% CI, -15.53 to -3.24; p = 0.003). The association with lower follow-up LAVI was also observed among patients without heart failure and remained similar in sensitivity analyses. During post-landmark follow-up, rhythm control was associated with a lower hazard of all-cause mortality or stroke hospitalization (adjusted HR, 0.46; 95% CI, 0.24-0.88; p = 0.019).
CONCLUSION: Pharmacological rhythm control was associated with more favorable longitudinal LA remodeling than rate control, including among patients without heart failure, and was also associated with a lower hazard of subsequent all-cause mortality or stroke hospitalization.
METHODS: This single-center retrospective cohort included 156 adults with paroxysmal or persistent AF receiving mutually exclusive pharmacological rate-control (n = 92) or rhythm-control (n = 64) therapy who underwent two transthoracic echocardiograms. LA remodeling was assessed using serial echocardiography, and clinical outcomes were evaluated after the second examination.
RESULTS: Among 74 patients with paired left atrial volume index (LAVI) measurements, LAVI increased from 39.9 to 50.3 mL/m2 with rate control (p < 0.001) but remained unchanged with rhythm control (44.9 to 43.4 mL/m2; p = 0.465). After adjustment for baseline LAVI and clinical covariates, rhythm control was associated with a 9.38 mL/m2 lower follow-up LAVI (95% CI, -15.53 to -3.24; p = 0.003). The association with lower follow-up LAVI was also observed among patients without heart failure and remained similar in sensitivity analyses. During post-landmark follow-up, rhythm control was associated with a lower hazard of all-cause mortality or stroke hospitalization (adjusted HR, 0.46; 95% CI, 0.24-0.88; p = 0.019).
CONCLUSION: Pharmacological rhythm control was associated with more favorable longitudinal LA remodeling than rate control, including among patients without heart failure, and was also associated with a lower hazard of subsequent all-cause mortality or stroke hospitalization.